Latest News
-

TRACK-HD reveals significant changes in pre-symptomatic HD mutation carriers and patients
The one-year report from the TRACK-HD study demonstrates a number of changes in pre-symptomatic HD-mutation carriers
HDBuzz Trial Tracker
Progress update for NCT06585449 – A Study to Evaluate ALN-HTT02
Alnylam Pharmaceuticals
Expected:
2026
Additional insights from Phase 2 study results and update on plans for Phase 3 trial for votoplam
Novartis/PTC Therapeutics
Expected:
Not disclosed
Updates from the ongoing placebo-controlled Phase 2/3 FALCON-HD trial
Skyhawk Therapeutics
Expected:
Not disclosed
Previously featured
-
A Guest Perspective for Gratitude Day: Why Huntingtonās Disease May Be Neuroscienceās Best Investment
-
The Girl at the End of the World: A Gratitude Day Reflection on the Place that Built Our Science
-
Turning down mismatch repair genes slows Huntingtonās repeat growth in human neurons
-
Huntingtonās Disease Therapeutics Conference 2026 ā Day 3
-
Huntingtonās Disease Therapeutics Conference 2026 ā Day 2
Follow HDBuzz
Sign up to our monthly email summary by entering your email address on our mailing list page.
Suggest an article
Is there something you want us to write about? Tell us about it here. We consider all suggestions but can’t promise to write content about any particular suggestion.
